- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02032121
Vascular Endothelial Inflammation and Dysfunction in Pediatric Long-term Cancer Survivors
September 8, 2015 updated by: Tracie L. Miller, MD, University of Miami
Survivors of childhood cancer have an increased risk of death from cardiovascular disease due to both the therapies they received while undergoing treatment and diet and lifestyle factors.
The nature of cardiovascular risk and the interaction between treatment affects and cardiovascular risk factors is unknown.
We propose to study vascular inflammatory markers as well as measure of blood vessel stiffness (both of which are predictive of early heart disease) in 100 pediatric cancer survivors and 100 control children.
Characterization of vascular inflammation and stiffness in long-term survivors will allow for the development of future interventions to decrease inflammation through both pharmacologic and lifestyle modifications.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
6
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33136
- University of Miami, Miller School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years to 28 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 6-30 years of age
- 2 years from the completion of therapy for cancer
- free of active disease
Exclusion Criteria:
- <6 or > 30 years of age
- current cancer treatment or inside of 2 years post treatment
- Active disease/infection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention procedures
All the procedures will be completed for every subject
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vascular Inflammation
Time Frame: single time point at initial visit
|
All study procedures to assess vascular inflammation will be assessed through specimen sample collection and through procedures such as (echocardiograph)
|
single time point at initial visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tracie L Miller, MD, SM, University of Miami
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2007
Primary Completion (Actual)
August 1, 2015
Study Completion (Actual)
August 1, 2015
Study Registration Dates
First Submitted
January 8, 2014
First Submitted That Met QC Criteria
January 8, 2014
First Posted (Estimate)
January 9, 2014
Study Record Updates
Last Update Posted (Estimate)
September 9, 2015
Last Update Submitted That Met QC Criteria
September 8, 2015
Last Verified
September 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20070584
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer Survivor
-
University of New MexicoNew Mexico State University; University of New Mexico Cancer CenterCompleted
-
Ohio State University Comprehensive Cancer CenterCompletedCancer SurvivorUnited States
-
University Health Network, TorontoPrincess Margaret Hospital, Canada; Canadian Breast Cancer FoundationCompletedBreast Cancer Survivor | Pediatric Cancer SurvivorCanada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Oncology Nursing Society; Villanova UniversityCompletedChildhood Cancer SurvivorUnited States
-
Turku University HospitalLounais-Suomen SyöpäyhdistysNot yet recruiting
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)WithdrawnCancer SurvivorUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Auburn UniversityCompleted
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedCancer SurvivorUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); National Institute of Mental Health (NIMH)CompletedCancer SurvivorUnited States
Clinical Trials on Echocardiography
-
Kang YanRecruiting
-
Lifetech Scientific (Shenzhen) Co., Ltd.RecruitingNon-valvular Atrial Fibrillation | Embolic StrokeChina
-
Assiut UniversityUnknownCORONARY ARTERY BYPASSEgypt
-
Assiut UniversityUnknownMyocardial Infarction | Left Ventricular Dysfunction | Echocardiography 2DEgypt
-
Milton S. Hershey Medical CenterCompletedEchocardiography, Transesophageal | Ventricular Function, RightUnited States
-
Assiut UniversityNot yet recruiting
-
Weill Medical College of Cornell UniversityWithdrawn3D Transesophageal and Transthoracic EchocardiogramUnited States
-
NHS Greater Glasgow and ClydeUniversity of Glasgow; Roche DiagnosticsRecruitingHeart Failure | Obesity | Heart Failure With Preserved Ejection FractionUnited Kingdom
-
Assiut UniversityNot yet recruiting
-
Ruijin HospitalRecruitingDiabetes Mellitus, Type 2 | Chronic Total Occlusion of Coronary ArteryChina